These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system. Lassila M, Davis BJ, Allen TJ, Burrell LM, Cooper ME, Cao Z. Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675 [Abstract] [Full Text] [Related]
4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [Abstract] [Full Text] [Related]
5. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M. J Am Coll Cardiol; 2006 Feb 21; 47(4):726-33. PubMed ID: 16487836 [Abstract] [Full Text] [Related]
6. Combined angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on survival and cardiac remodeling in chronic heart failure in rats. Richer C, Fornes P, Domergue V, De Gasparo M, Giudicelli JF. J Card Fail; 2001 Sep 21; 7(3):269-76. PubMed ID: 11561229 [Abstract] [Full Text] [Related]
7. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha. Makino T, Hattori Y, Matsuda N, Onozuka H, Sakuma I, Kitabatake A. J Pharmacol Exp Ther; 2003 Jan 21; 304(1):370-9. PubMed ID: 12490614 [Abstract] [Full Text] [Related]
8. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, Warnica JW, Khrakovskaya M, Arnold JM, Schwartz Y, Velazquez EJ, Califf RM, McMurray JV, Pfeffer MA. Circulation; 2005 Jun 28; 111(25):3411-9. PubMed ID: 15967846 [Abstract] [Full Text] [Related]
9. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors. Rehman A, Rahman AR, Rasool AH. J Hum Hypertens; 2002 Apr 28; 16(4):261-6. PubMed ID: 11967720 [Abstract] [Full Text] [Related]
10. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems. Spinale FG, de Gasparo M, Whitebread S, Hebbar L, Clair MJ, Melton DM, Krombach RS, Mukherjee R, Iannini JP, O SJ. Circulation; 1997 Oct 07; 96(7):2385-96. PubMed ID: 9337215 [Abstract] [Full Text] [Related]
11. Endothelin-1 receptor blockade induces upregulation of renin-angiotensin-aldosterone system expression in terms of blood pressure regulation. Bo Yang, Chen YD, Li TD, Feng QZ. J Renin Angiotensin Aldosterone Syst; 2010 Jun 07; 11(2):119-23. PubMed ID: 20093323 [Abstract] [Full Text] [Related]
12. Effect of captopril cardioplegia on renin-angiotensin system, prostaglandins, free radicals and electrolytes in the isolated hypothermic ischemic and reperfusion rabbit hearts. Liu FM, Xu SC. Chin Med J (Engl); 1993 Dec 07; 106(12):903-6. PubMed ID: 8143507 [Abstract] [Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibitor versus valsartan on cellular signaling events in heart transplant. White M, Ross H, Levesque S, Whittom L, Pelletier GB, Racine N, Meloche S, Voisin L. Ann Pharmacother; 2009 May 07; 43(5):831-9. PubMed ID: 19417110 [Abstract] [Full Text] [Related]
14. [Activation of the renin-angiotensin system and blood pressure variability in rats]. Blanc J, Lambert G, Elghozi JL. Arch Mal Coeur Vaiss; 2000 Aug 07; 93(8):1019-22. PubMed ID: 10989749 [Abstract] [Full Text] [Related]
15. Angiotensin converting enzyme inhibitors or DuP753 prevent neointimal formation following balloon injury with single topical or multiple systemic application. Taguchi J, Abe J, Okazaki H, Ochiai M, Ohno M, Takuwa Y, Kurokawa K. Biochem Biophys Res Commun; 1993 Oct 29; 196(2):969-74. PubMed ID: 8240375 [Abstract] [Full Text] [Related]
16. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure. Nekooeian AA, Ogilvie RI, Zborowska-Sluis D. Can J Cardiol; 1995 Jan 29; 11(1):59-64. PubMed ID: 7850666 [Abstract] [Full Text] [Related]
17. Pharmacology of ACE inhibitors versus AT1 blockers. Vaughan D. Can J Cardiol; 2000 Aug 29; 16 Suppl E():36E-40E. PubMed ID: 10906625 [Abstract] [Full Text] [Related]
18. Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone. Abdelrahman AM, Burrell LM, Johnston CI. J Hypertens Suppl; 1993 Apr 29; 11(3):S23-6. PubMed ID: 8315514 [Abstract] [Full Text] [Related]
19. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes. Spinale FG, Mukherjee R, Iannini JP, Whitebread S, Hebbar L, Clair MJ, Melton DM, Cox MH, Thomas PB, de Gasparo M. Circulation; 1997 Oct 07; 96(7):2397-406. PubMed ID: 9337216 [Abstract] [Full Text] [Related]